← All Standard Biotools INC filings

Standard Biotools INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
LAB
Standard Biotools INC
DEF: Standard BioTools Sets June 17th Annual Meeting Date
Standard BioTools Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, with several key proposals for shareholder vote.
NASDAQ
LAB
Standard Biotools INC
DEFA14A: Standard BioTools Inc. Files Definitive Proxy Statement
Standard BioTools Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
LAB
Standard Biotools INC
DEF: Standard BioTools Seeks Stockholder Approval for Equity Incentive Plan Amendment
Standard BioTools is asking stockholders to approve an amendment to its 2011 Equity Incentive Plan to increase the number of shares available for issuance by 17,400,000.
NASDAQ
LAB
Standard Biotools INC
DEFA14A: Standard BioTools Inc. Resolves Proxy Contest with Madryn, Updates Proxy Statement
Madryn Investment Management withdraws its director nominees and proposal to declassify the board at Standard BioTools' upcoming annual meeting, leading to an updated proxy statement and a new WHITE proxy card.
NASDAQ
LAB
Standard Biotools INC
DEFC14A: Standard BioTools Aims for Growth After SomaLogic Merger, Faces Board Challenge
Standard BioTools highlights 2023 achievements, including revenue growth and cost reductions, while facing a proxy fight from Madryn Health Partners at the upcoming annual meeting.